查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1776189

胸腔引流导管的全球市场:洞察，竞争情形，市场预测:2032年

Chest Drainage Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计在2025年至2032年的预测期内，胸腔引流导管市场的复合年增长率将达到4.78%。胸腔引流导管的需求受到多种关键因素的驱动，其中包括全球日益增多的慢性疾病，这些疾病通常需要进行胸腔引流干预，例如癌症、心血管疾病、恶性胸腔积液、气胸、血胸和心包膜积液。这些疾病负担的加重，加上导管技术的进步、医疗保健可近性的提高以及主要市场参与者持续的产品创新，正在创造有利于市场扩张的环境。这些因素共同推动了2025年至2032年预测期内胸腔引流导管的需求，并强化了其在现代医学中的关键作用。

胸腔引流管市场动态：

根据国际癌症研究机构 (2024) 的数据，2022 年共报告了 2,486,750 例气管癌、支气管癌和肺癌病例。亚洲占总数的 63.1%。

这些癌症，尤其是肺癌，通常伴随復发性胸腔积液，通常使用隧道式或非隧道式胸腔引流管进行安宁疗护和治癒治疗。癌症负担的增加，尤其是晚期癌症，直接增加了医院、肿瘤中心和家庭医疗保健机构对此类导管系统的需求。

除肿瘤外，心血管疾病的流行也是关键驱动因素。根据英国心臟基金会 (2024) 的数据，全球约有 6.2 亿人患有心臟和循环系统疾病，每 13 人中就有 1 人受到影响。心臟病发作和心臟手术等心血管事件常常会导致心包膜积液和术后积液，因此需要使用闭式胸腔引流导管来预防心包膜填塞并促进復健。

此外，微创、数位化和影像导引手术的日益普及，显着促进了胸腔引流导管市场的发展，提高了手术准确性、病人安全性和復健效果。微创手术因其减少创伤、降低感染风险和缩短住院时间而受到临床医生和患者的青睐。影像导引导管置入，尤其是使用超音波和萤光透视，能够实现精确定位，并最大限度地减少组织损伤和错位等併发症。数位技术的进步，例如配备流量感测器和压力监测器的智慧导管，能够实现即时引流监测、併发症的早期发现以及术后管理的改善。这些进步不仅提高了临床效率和患者预后，也符合全球医疗保健趋势，即青睐门诊护理和经济高效的解决方案。

因此，全球癌症和心臟病负担的不断增加，推动了对安全、有效和微创胸腔引流解决方案的需求，预计这将在2025年至2032年的预测期内显着推动胸腔引流导管市场的增长。

然而，胸腔引流导管的复杂性和局限性，以及严格的监管要求，是可能限制胸腔引流导管市场成长的主要限制因素。

胸腔引流管市场区隔分析：

产品类型（胸腔引流管、胸腔引流管、套管针导管、其他）、材质（硅胶、PVC（聚氯乙烯）、其他）、应用（心胸外科、胸腔积液、创伤外科、气胸、其他）、最终用户（医院、门诊手术中心、其他）、地区（北美、欧洲、亚太地区、其他）

按产品类型划分的胸腔引流管市场中，预计胸腔引流管类别将在2024年占据最大的市场占有率。由于胸腔引流管在胸腔积水、气胸、血胸和其他需要胸腔引流管治疗的胸部疾病中的应用日益增多，因此它正在显着推动整个胸腔引流管市场的发展。从胸腔排出液体或空气。随着肺癌、充血性心臟衰竭、感染和创伤等相关胸膜疾病发生率的上升，无论是在急性护理还是长期照护环境中，对胸腔引流解决方案的需求都在稳步增长。

这些导管，尤其是像 PleurX™ 系统这样的隧道式留置胸腔导管 (TIPC)，已成为治疗復发性或慢性胸腔积液的首选解决方案，为反复胸腔穿刺和住院手术提供了一种创伤性更小、更方便患者的门诊替代方案。这些导管为反覆胸腔穿刺和住院手术提供了创伤性较小、更方便患者的替代方案，使门诊甚至居家照护成为可能。这种向微创和门诊治疗的转变与更广泛的医疗保健趋势一致，包括控製成本、缩短住院时间和提高患者舒适度，从而扩大了胸腔引流导管的市场潜力。

此外，导管设计的进步，例如更小直径的导管以提高引流效率、抗菌涂层以及与数位引流系统的集成，正在提高安全性和临床疗效，进一步推动其应用。因此，製造商正在投资扩大其胸腔导管产品组合，瞄准已开发市场和新兴市场。加之不断增长的临床需求、技术创新、病患对微创治疗的偏好，以及胸腔引流导管在肿瘤学和安宁疗护中的日益普及，胸腔引流导管已成为推动整个胸腔引流导管市场成长的关键驱动力。

鑑于这些趋势，预计在2025年至2032年的预测期内，胸腔引流导管类别将实现显着增长，从而显着促进整个胸腔引流导管市场的扩张。

预计北美将主导整个胸腔引流导管市场：

预计到2024年，北美将在胸腔引流导管市场占据最大占有率，这主要得益于几个关键因素。这一区域主导地位主要源自于人口趋势、临床需求和技术进步，这些因素共同促成了强劲的市场需求。主要的成长动力是癌症患者数量的增加，尤其是胸腔积水患者，这些患者通常使用胸腔引流导管进行治疗。此外，主要市场参与者的存在和完善的医疗保健基础设施进一步巩固了北美在2025年至2032年预测期内作为胸腔引流导管领先市场的地位。

例如，根据GLOBOCAN (2024) 的数据，美国报告了226,033例气管癌、支气管癌和肺癌病例，占该地区癌症病例的87.9%。同样，加拿大在2022年记录了31,157例。这些癌症通常会导致恶性胸腔积水等併发症，需要进行胸腔干预，包括胸腔引流导管，以有效管理液体。随着这些疾病的盛行率持续上升，对可靠且高效的引流系统的需求也在增长，从而推动了市场的成长。

此外，美国老年人口的成长也显着促进了市场扩张。老年人更容易患有肿瘤疾病和慢性心肺疾病，这些疾病通常需要胸部干预，包括胸腔引流系统。对早期诊断和及时干预以管理肺部和心臟周围积液的需求日益增长，这推动了医疗机构对胸腔引流导管的采用。

心血管疾病也是推动需求的关键因素。根据美国疾病管制与预防中心 (CDC, 2024) 的数据，美国每 20 名 20 岁及以上成年人中就有 1 名患有冠心病，每年约有 805,000 人心臟病发作。

许多此类病例需要术后引流或处理心包膜积液，而胸腔引流导管通常用于预防併发症和促进復健。

此外，完善的医疗保健基础设施、强有力的报销政策以及 BD、Cook 和 Teleflex Incorporated 等主要市场参与者的存在，使该地区成为未来几年全球胸腔引流导管市场的主要贡献者。

综合来看，上述因素预计将在2025年至2032年的预测期内重振北美胸腔引流导管市场。

胸腔引流导管市场的主要参与者

胸腔引流导管市场的主要参与者包括 BD、Teleflex Incorporated、Cook、ICU Medical、Redax S.p.A.、Cardinal Health、Mediplus Ltd.、Medela AG、Rocket Medical plc.、Utah Medical Products, Inc.、ANGIPLAST PRIVATE LIMITED、Vygon、Getinge Ltd、Poly.

胸腔引流导管市场的最新发展：

  • 2021年6月，全球领先的医疗科技公司 BD 宣布已获得美国食品药物管理局的 510(k) 许可。美国食品药物管理局 (FDA) 已批准其 PeritX™ 腹膜导管系统。此系统用于引流症状性、復发性、非恶性腹水，其特征为腹腔内积水。

胸腔引流管市场研究报告的主要发现

  • 目前胸腔引流管市场规模分析（2024 年）及八年市场预测（2025-2032 年）
  • 过去三年主要产品/技术发展、合併、收购、合作及合资企业
  • 主导胸腔引流管市场的主要公司
  • 胸腔引流管市场中竞争对手面临的各种机会
  • 哪些细分市场将在 2024 年名列前茅？ 2032 年各细分市场的表现
  • 目前胸腔引流导管市场中排名靠前的地区和国家
  • 未来企业应关注胸腔引流导管市场成长机会的地区和国家

本胸腔引流导管市场研究报告的目标对象

  • 胸腔引流导管产品供应商
  • 研究机构和顾问公司
  • 胸腔引流导管相关组织、协会、论坛等
  • 政府机构与企业
  • 新创公司、创投公司和私人企业
  • 胸腔引流导管经销商和贸易商
  • 有兴趣了解更多胸腔引流导管市场及最新技术发展的各类终端用户

胸腔引流导管市场常见问题

1.什么是胸腔引流管？

  • 胸腔引流管又称胸腔导管或胸膜导管。胸腔引流管是一种柔性管，插入胸腔或纵隔，用于排出肺部和心臟周围的空气、液体、血液和脓液。它们对于治疗气胸、血胸和胸腔积水等疾病以及胸部或心臟手术后的引流至关重要。这些导管有助于恢復正常呼吸，防止肺部塌陷，并降低感染和其他併发症的风险。它们常用于急诊、外科和重症监护。

2.胸腔引流导管的市场

  • 预计在 2025 年至 2032 年的预测期内，胸腔引流管市场将以 4.78% 的复合年增长率成长。

3.胸腔引流管市场驱动因素

  • 胸腔引流管的需求受到多种关键因素的驱动，包括全球范围内癌症、心血管疾病、恶性胸腔积液、气胸、血胸和心包积液等慢性疾病的患病率不断上升，这些疾病通常需要进行胸腔引流干预。这些疾病负担的日益加重，加上导管技术的进步、医疗保健可及性的提高以及主要市场参与者持续的产品创新，正在创造有利于市场扩张的环境。这些综合因素在2025年至2032年的预测期内推动了胸腔引流管的需求，并强化了胸腔引流管在现代医学中的关键作用。

4.胸腔引流导管市场的主要公司

  • 胸腔引流导管市场的主要参与者包括 BD、Teleflex Incorporated、Cook、ICU Medical、Redax S.p.A.、Cardinal Health、Mediplus Ltd.、Medela AG、Rocket Medical plc.、Utah Medical Products, Inc.、ANGIPLAST PRIVATE LIMITED、Vygon、Getinge Ltd、Poly.

5. 胸腔引流导管市场中市占率最大的地区

  • 预计北美将在 2024 年占据胸腔引流导管市场的最大占有率，这基于以下几个关键因素：这一区域优势可以归因于人口趋势、临床需求和技术进步的共同作用，这些因素共同促成了强劲的市场需求。主要的成长动力是癌症患者数量的增加，尤其是胸腔积水患者，通常使用胸腔引流导管进行治疗。此外，主要市场参与者的存在和完善的医疗保健基础设施进一步巩固了北美在2025年至2032年预测期内作为胸腔引流导管领先市场的地位。

目录

第1章 胸腔引流导管市场报告的简介

第2章 胸腔引流导管市场摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 胸腔引流导管市场主要原因分析

  • 胸腔引流导管推动市场要素
    • 慢性病发生率上升
    • 微创、数位化和影像导引手术的普及率不断提高
  • 胸腔引流管市场的限制与课题
    • 胸腔引流管的复杂性与局限性
    • 严格的监理要求
  • 胸腔引流管市场机会
    • 导管设计的创新，例如具有防扭结和抗菌涂层的小直径和生物相容性导管

第6章 胸腔引流导管市场:波特的五力分析

第7章 胸腔引流导管市场评估

  • 各产品类型
    • 胸部导管
    • 胸膜引流导管
    • 穿刺套管导管
    • 其他
  • 不同材料
    • 硅胶
    • PVC(聚氯乙烯)
  • 各用途
    • 心臟胸部外科
    • 胸水
    • 外伤手术
    • 气胸
  • 各终端用户
    • 医院
    • 门诊病人手术中心
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 胸腔引流导管市场企业与产品简介

  • BD
  • Teleflex Incorporated
  • Cook
  • ICU Medical
  • Redax S.p.A.
  • Cardinal Health
  • Mediplus Ltd.
  • Medela AG
  • Rocket Medical plc.
  • Utah Medical Products, Inc.
  • ANGIPLAST PRIVATE LIMITED
  • Vygon
  • Getinge AB
  • Poly Medicure Ltd.
  • Sterimed Group

第9章 KOL的见解

第10章 计划方法

第11章 关于DelveInsight

第12章 免责声明和咨询方式

Product Code: DIMDCL0189

Chest Drainage Catheters Market by Product Type (Thoracic Catheters, Pleural Drainage Catheters, Trocar Catheters, and Others), Material (Silicone, PVC (Polyvinyl Chloride), and Others), Application (Cardiothoracic Surgery, Pleural Effusion, Trauma Surgery, Pneumothorax, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising instances of chronic disorders and increased adoption of minimally invasive, digital, and image-guided procedures across the world.

The chest drainage catheters market is estimated to grow at a CAGR of 4.78% during the forecast period from 2025 to 2032. The demand for chest drainage catheters is being driven by several critical factors, including the rising global prevalence of chronic conditions such as cancer, cardiovascular diseases, malignant pleural effusions, pneumothorax, hemothorax, and pericardial effusions, all of which frequently require thoracic drainage interventions. The growing burden of these conditions, along with advancements in catheter technology, increased healthcare access, and continued product innovation by key market players, is creating a supportive environment for market expansion. Collectively, these factors are propelling demand and reinforcing the critical role of chest drainage catheters in modern clinical care during the forecast period from 2025 to 2032.

Chest Drainage Catheters Market Dynamics:

According to data from the International Agency for Research on Cancer (2024), in the year 2022, there were 24,80,675 reported cases of Trachea, bronchus, and lung cancer. Out of which Asia accounted for 63.1% of all the cases.

These types of cancers, particularly lung are often associated with recurrent pleural effusions, a condition managed using tunneled or non-tunneled chest drainage catheters for palliative and therapeutic care. The growing cancer burden, especially in advanced-stage disease, is directly increasing the demand for such catheter systems across hospitals, oncology centers, and home care settings.

In addition to oncology, the prevalence of cardiovascular diseases is also a significant driver. According to the British Heart Foundation (2024), approximately 620 million people globally were living with heart and circulatory diseases, and 1 in 13 individuals worldwide was affected by such conditions. Cardiovascular events, such as heart attacks and cardiac surgeries, frequently result in pericardial effusions or postoperative fluid accumulation, necessitating the use of closed-system chest drainage catheters to prevent cardiac tamponade and promote recovery.

Furthermore, the increased adoption of minimally invasive, digital, and image-guided procedures is significantly boosting the chest drainage catheter market by enhancing procedural precision, patient safety, and recovery outcomes. Minimally invasive techniques reduce trauma, lower the risk of infection, and shorten hospital stays, making them highly preferred by both clinicians and patients. Image-guided catheter placements especially those using ultrasound or fluoroscopy enable accurate positioning, minimizing complications such as tissue damage or malposition. Digital innovations, such as smart catheters equipped with flow sensors and pressure monitors, are enabling real-time drainage monitoring, early detection of complications, and better postoperative management. These advancements not only improve clinical efficiency and patient outcomes but also align with global healthcare trends favoring outpatient care and cost-effective solutions.

Therefore, the increasing global burden of cancer and heart disease is driving the need for safe, effective, and minimally invasive thoracic drainage solutions, which in turn is expected to significantly boost the growth of the chest drainage catheters market during the forecast period from 2025 to 2032.

However, the complexity and limitations associated with chest drainage catheters, and stringent regulatory requirements, among others are some of the key constraints that may limit the growth of the chest drainage catheters market.

Chest Drainage Catheters Market Segment Analysis:

Product Type (Thoracic Catheters, Pleural Drainage Catheters, Trocar Catheters, and Others), Material (Silicone, PVC (Polyvinyl Chloride), and Others), Application (Cardiothoracic Surgery, Pleural Effusion, Trauma Surgery, Pneumothorax, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the chest drainage catheters market, the pleural drainage catheters category is estimated to account for the largest market share in 2024. Pleural drainage catheters are significantly boosting the overall chest drainage catheter market due to their growing use in the management of pleural effusions, pneumothorax, hemothorax, and other thoracic conditions requiring fluid or air evacuation from the pleural cavity. With the rising incidence of pleural diseases often linked to lung cancer, congestive heart failure, infections, and trauma the demand for pleural drainage solutions has increased steadily across both acute care and long-term care settings.

These catheters, especially tunneled indwelling pleural catheters (TIPCs) such as the PleurX(TM) system, have become the preferred solution for managing recurrent or chronic pleural fluid accumulation, offering a less invasive, outpatient-based alternative to repeated thoracentesis or hospital-based procedures. These catheters, offer a less invasive and more patient-friendly alternative to repeated thoracentesis and hospital-based procedures, enabling outpatient and even home-based care. This shift toward minimally invasive and ambulatory care practices aligns with broader healthcare trends, including cost containment, reduced hospital stays, and improved patient comfort, which in turn expands the market potential for pleural drainage catheters.

Furthermore, ongoing advancements in catheter design such as smaller diameter catheters with better drainage efficiency, anti-microbial coatings, and integration with digital drainage systems are enhancing safety and clinical outcomes, further encouraging adoption. As a result, manufacturers are investing in expanding their pleural catheter product portfolios, targeting both developed and emerging markets. Collectively, the rising clinical demand, technological innovation, patient preference for less invasive care, and the expanding use of pleural drainage catheters in cancer and palliative care are making them a critical driver of growth in the overall chest drainage catheter market.

Given these trends, the pleural drainage catheters category is expected to generate substantial growth and significantly contribute to the overall expansion of the chest drainage catheters market throughout the forecast period of 2025 to 2032.

North America is expected to dominate the overall chest drainage catheters market:

North America is projected to hold the largest share of the chest drainage catheters market in 2024, driven by several key factors. This regional dominance is largely driven by a combination of demographic trends, clinical needs, and technological advancements that collectively contribute to strong market demand. A key growth factor is the increasing number of cancer patients, particularly those suffering from malignant pleural effusions, a condition commonly managed with chest drainage catheters. Additionally, the presence of key market players and a well-established healthcare infrastructure further solidify North America's position as the leading market for chest drainage catheters throughout the forecast period from 2025 to 2032.

For instance, according to GLOBOCAN (2024), the United States reported 226,033 cases of trachea, bronchus, and lung cancers, accounting for 87.9% of such cases in the region. Similarly, Canada recorded 31,157 cases in 2022. These cancers frequently lead to complications such as malignant pleural effusions, which require thoracic interventions involving chest drainage catheters for effective fluid management. As the prevalence of these conditions continues to rise, so does the need for reliable and efficient drainage systems, thereby propelling market growth.

Furthermore, the growing geriatric population in the U.S. is significantly contributing to market expansion. Older adults are more prone to developing both oncological conditions and chronic cardiopulmonary diseases, which often require thoracic interventions involving chest drainage systems. The increasing need for early diagnosis and timely intervention in managing fluid accumulation around the lungs and heart is propelling the adoption of chest drainage catheters across healthcare facilities.

Cardiovascular diseases are another key factor fueling demand. According to the Centers for Disease Control and Prevention (CDC, 2024), 1 in 20 adults aged 20 and older suffers from coronary heart disease in the U.S., and approximately 805,000 people experience heart attacks annually.

Many of these cases require post-surgical drainage or management of pericardial effusions, where chest drainage catheters are routinely employed to prevent complications and support recovery.

In addition, the supportive healthcare infrastructure, strong reimbursement policies, and the presence of key market players such as BD, Cook, and Teleflex Incorporated also position the region as a dominant contributor to the global chest drainage catheters market in the upcoming years.

Collectively, the aforementioned factors are expected to boost the market for chest drainage catheters in North America during the forecast period from 2025 to 2032.

Chest Drainage Catheters Market Key Players:

Some of the key market players operating in the chest drainage catheters market include BD, Teleflex Incorporated, Cook, ICU Medical, Redax S.p.A., Cardinal Health, Mediplus Ltd., Medela AG, Rocket Medical plc., Utah Medical Products, Inc., ANGIPLAST PRIVATE LIMITED, Vygon, Getinge AB, Poly Medicure Ltd., Sterimed Group, and others.

Recent Developmental Activities in the Chest Drainage Catheters Market:

  • In June 2021, BD, a global leader in medical technology, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PeritX(TM) Peritoneal Catheter System. The device is intended for the drainage of symptomatic, recurrent non-malignant ascites, a debilitating condition characterized by the accumulation of fluid in the abdominal cavity.

Key takeaways from the chest drainage catheters market report study

  • Market size analysis for current chest drainage catheters market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the chest drainage catheters market.
  • Various opportunities available for the other competitors in the chest drainage catheters market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current chest drainage catheters market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for chest drainage catheter market growth in the coming future?

Target audience who can benefit from this chest drainage catheters market report study

  • Chest drainage catheter product providers
  • Research organizations and consulting companies
  • Chest drainage catheters-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in chest drainage catheters
  • Various end-users who want to know more about the chest drainage catheters market and the latest technological developments in the chest drainage catheters market.

Frequently Asked Questions for the Chest Drainage Catheters Market:

1. What are chest drainage catheters?

  • Chest drainage catheters, also known as thoracic or pleural catheters, are flexible tubes inserted into the pleural space or mediastinum to remove air, fluid, blood, or pus from around the lungs or heart. They are essential in treating conditions such as pneumothorax, hemothorax, pleural effusion, and postoperative drainage following thoracic or cardiac surgery. These catheters help restore normal breathing mechanics, prevent lung collapse, and reduce the risk of infection or other complications. They are commonly used in emergency, surgical, and critical care settings.

2. What is the market for chest drainage catheters?

  • The chest drainage catheters market is estimated to grow at a CAGR of 4.78% during the forecast period from 2025 to 2032.

3. What are the drivers for the chest drainage catheters market?

  • The demand for chest drainage catheters is being driven by several critical factors, including the rising global prevalence of chronic conditions such as cancer, cardiovascular diseases, malignant pleural effusions, pneumothorax, hemothorax, and pericardial effusions, all of which frequently require thoracic drainage interventions. The growing burden of these conditions, along with advancements in catheter technology, increased healthcare access, and continued product innovation by key market players, is creating a supportive environment for market expansion. Collectively, these factors are propelling demand and reinforcing the critical role of chest drainage catheters in modern clinical care during the forecast period from 2025 to 2032

4. Who are the key players operating in the chest drainage catheters market?

  • Some of the key market players operating in the chest drainage catheters market include BD, Teleflex Incorporated, Cook, ICU Medical, Redax S.p.A., Cardinal Health, Mediplus Ltd., Medela AG, Rocket Medical plc., Utah Medical Products, Inc., ANGIPLAST PRIVATE LIMITED, Vygon, Getinge AB, Poly Medicure Ltd., Sterimed Group, and others.

5. Which region has the highest share in the chest drainage catheters market?

  • North America is projected to hold the largest share of the chest drainage catheters market in 2024, driven by several key factors. This regional dominance is largely driven by a combination of demographic trends, clinical needs, and technological advancements that collectively contribute to strong market demand. A key growth factor is the increasing number of cancer patients, particularly those suffering from malignant pleural effusions, a condition commonly managed with chest drainage catheters. Additionally, the presence of key market players and a well-established healthcare infrastructure further solidify North America's position as the leading market for chest drainage catheters throughout the forecast period from 2025 to 2032.

Table of Contents

1. Chest Drainage Catheters Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Chest Drainage Catheters Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Chest Drainage Catheters Market Key Factors Analysis

  • 5.1. Chest Drainage Catheters Market Drivers
    • 5.1.1. Rising instances of chronic disorders
    • 5.1.2. Increased adoption of minimally invasive, digital, and image-guided procedure
  • 5.2. Chest Drainage Catheters Market Restraints and Challenges
    • 5.2.1. Complexity and limitations associated with chest drainage catheters
    • 5.2.2. Stringent regulatory requirement
  • 5.3. Chest Drainage Catheters Market Opportunity
    • 5.3.1. Innovation in catheter design such as smaller-bore and biocompatible catheters with anti-kinking and anti-microbial coatings

6. Chest Drainage Catheters Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Chest Drainage Catheters Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Thoracic Catheters
    • 7.1.2. Pleural Drainage Catheters
    • 7.1.3. Trocar Catheters
    • 7.1.4. Others
  • 7.2. By Material
    • 7.2.1. Silicone
    • 7.2.2. PVC (Polyvinyl Chloride)
    • 7.2.3. Others
  • 7.3. By Application
    • 7.3.1. Cardiothoracic Surgery
    • 7.3.2. Pleural Effusion
    • 7.3.3. Trauma Surgery
    • 7.3.4. Pneumothorax
    • 7.3.5. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.1.2. Canada Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.1.3. Mexico Chest Drainage Catheters Market Size in USD million (2022-2032)
    • 7.5.2. Europe
      • 7.5.2.1. France Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.2. Germany Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.3. United Kingdom Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.4. Italy Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.5. Spain Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.2.6. Rest of Europe Chest Drainage Catheters Market Size in USD million (2022-2032)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.2. Japan Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.3. India Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.4. Australia Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.5. South Korea Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.3.6. Rest of Asia-Pacific Chest Drainage Catheters Market Size in USD million (2022-2032)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.4.2. Africa Chest Drainage Catheters Market Size in USD million (2022-2032)
      • 7.5.4.3. South America Chest Drainage Catheters Market Size In USD Million (2022-2032)

8. Chest Drainage Catheters Market Company and Product Profiles

  • 8.1. BD
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Teleflex Incorporated
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Cook
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ICU Medical
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Redax S.p.A.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Cardinal Health
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Mediplus Ltd.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medela AG
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Rocket Medical plc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Utah Medical Products, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. ANGIPLAST PRIVATE LIMITED
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Vygon
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Getinge AB
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Poly Medicure Ltd.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Sterimed Group
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Chest Drainage Catheters Market in Global (2022-2032)
  • Table 3: Chest Drainage Catheters Market in Global by Product Type (2022-2032)
  • Table 4: Chest Drainage Catheters Market in Global by Material (2022-2032)
  • Table 5: Chest Drainage Catheters Market in Global by Application (2022-2032)
  • Table 6: Chest Drainage Catheters Market in Global by End-User (2022-2032)
  • Table 7: Chest Drainage Catheters Market in Global by Geography (2022-2032)
  • Table 8: Chest Drainage Catheters Market in North America (2022-2032)
  • Table 9: Chest Drainage Catheters Market in the United States (2022-2032)
  • Table 10: Chest Drainage Catheters Market in Canada (2022-2032)
  • Table 11: Chest Drainage Catheters Market in Mexico (2022-2032)
  • Table 12: Chest Drainage Catheters Market in Europe (2022-2032)
  • Table 13: Chest Drainage Catheters Market in France (2022-2032)
  • Table 14: Chest Drainage Catheters Market in Germany (2022-2032)
  • Table 15: Chest Drainage Catheters Market in United Kingdom (2022-2032)
  • Table 16: Chest Drainage Catheters Market in Italy (2022-2032)
  • Table 17: Chest Drainage Catheters Market in Spain (2022-2032)
  • Table 18: Chest Drainage Catheters Market in the Rest of Europe (2022-2032)
  • Table 19: Chest Drainage Catheters Market in Asia-Pacific (2022-2032)
  • Table 20: Chest Drainage Catheters Market in China (2022-2032)
  • Table 21: Chest Drainage Catheters Market in Japan (2022-2032)
  • Table 22: Chest Drainage Catheters Market in India (2022-2032)
  • Table 23: Chest Drainage Catheters Market in Australia (2022-2032)
  • Table 24: Chest Drainage Catheters Market in South Korea (2022-2032)
  • Table 25: Chest Drainage Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Chest Drainage Catheters Market in the Rest of the World (2022-2032)
  • Table 27: Chest Drainage Catheters Market in the Middle East (2022-2032)
  • Table 28: Chest Drainage Catheters Market in Africa (2022-2032)
  • Table 29: Chest Drainage Catheters Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Chest Drainage Catheters Market in Global (2022-2032)
  • Figure 3: Chest Drainage Catheters Market in Global by Product Type (2022-2032)
  • Figure 4: Chest Drainage Catheters Market in Global by Material (2022-2032)
  • Figure 5: Chest Drainage Catheters Market in Global by Application (2022-2032)
  • Figure 6: Chest Drainage Catheters Market in Global by End-User (2022-2032)
  • Figure 7: Chest Drainage Catheters Market in Global by Geography (2022-2032)
  • Figure 8: Chest Drainage Catheters Market in North America (2022-2032)
  • Figure 9: Chest Drainage Catheters Market in the United States (2022-2032)
  • Figure 10: Chest Drainage Catheters Market in Canada (2022-2032)
  • Figure 11: Chest Drainage Catheters Market in Mexico (2022-2032)
  • Figure 12: Chest Drainage Catheters Market in Europe (2022-2032)
  • Figure 13: Chest Drainage Catheters Market in France (2022-2032)
  • Figure 14: Chest Drainage Catheters Market in Germany (2022-2032)
  • Figure 15: Chest Drainage Catheters Market in United Kingdom (2022-2032)
  • Figure 16: Chest Drainage Catheters Market in Italy (2022-2032)
  • Figure 17: Chest Drainage Catheters Market in Spain (2022-2032)
  • Figure 18: Chest Drainage Catheters Market in the Rest of Europe (2022-2032)
  • Figure 19: Chest Drainage Catheters Market in Asia-Pacific (2022-2032)
  • Figure 20: Chest Drainage Catheters Market in China (2022-2032)
  • Figure 21: Chest Drainage Catheters Market in Japan (2022-2032)
  • Figure 22: Chest Drainage Catheters Market in India (2022-2032)
  • Figure 23: Chest Drainage Catheters Market in Australia (2022-2032)
  • Figure 24: Chest Drainage Catheters Market in South Korea (2022-2032)
  • Figure 25: Chest Drainage Catheters Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Chest Drainage Catheters Market in the Rest of the World (2022-2032)
  • Figure 27: Chest Drainage Catheters Market in the Middle East (2022-2032)
  • Figure 28: Chest Drainage Catheters Market in Africa (2022-2032)
  • Figure 29: Chest Drainage Catheters Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis